Oxime-Based Click Chemistry in the Development of 3-Isoxazolecarboxylic Acid Containing Inhibitors of Yersinia pestis Protein Tyrosine Phosphatase, YopH

被引:14
作者
Bahta, Medhanit [1 ]
Burke, Terrence R., Jr. [1 ]
机构
[1] NCI, Biol Chem Lab, Mol Discovery Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
aminooxy platform; docking studies; inhibitors; oxime-based click chemistry; substrate screening; PROMISCUOUS INHIBITORS; BIDENTATE INHIBITORS; PURIFICATION; PHOSPHOTYROSINE; IDENTIFICATION; OVERPRODUCTION; MECHANISM; MIMETICS; LIGATION; DESIGN;
D O I
10.1002/cmdc.201100200
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The pathogenicity of Yersinia pestis relies on several effector proteins including YopH, a protein tyrosine phosphatase (PTP). We previously screened a library of analogues based on the ubiquitous PTP substrate para-nitrophenylphosphate (pNPP) and found that incorporation of a 3-phenyl substituent to give 6-nitro-[1,1'-biphenyl]-3-yldihydrogen phosphate (1) enhanced affinity. Herein we report the conversion of 1 from a substrate into an inhibitor by replacing the hydrolysable phosphoryl group with a 3-isoxazolecarboxylic acid moiety and by introduction of an aminooxy group and subsequent diversification using oxime-based click chemistry. This approach led to the identification of non-promiscuous bidentate YopH inhibitors with affinity in the low micromolar range.
引用
收藏
页码:1363 / 1370
页数:8
相关论文
共 37 条
[1]  
ABAGYAN R, 2009, USER GUIDE 3 6
[2]   Utilization of Nitrophenylphosphates and Oxime-Based Ligation for the Development of Nanomolar Affinity Inhibitors of the Yersinia pestis Outer Protein H (YopH) Phosphatase [J].
Bahta, Medhanit ;
Lountos, George T. ;
Dyas, Beverly ;
Kim, Sung-Eun ;
Ulrich, Robert G. ;
Waugh, David S. ;
Burke, Terrence R., Jr. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (08) :2933-2943
[3]   Engineering non-natural inhibitor sensitivity in protein tyrosine phosphatase H1 [J].
Blair, ER ;
Hoffman, HE ;
Bishop, AC .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (02) :464-471
[4]   NONHYDROLYZABLE PHOSPHOTYROSYL MIMETICS FOR THE PREPARATION OF PHOSPHATASE-RESISTANT SH2 DOMAIN INHIBITORS [J].
BURKE, TR ;
SMYTH, MS ;
OTAKA, A ;
NOMIZU, M ;
ROLLER, PP ;
WOLF, G ;
CASE, R ;
SHOELSON, SE .
BIOCHEMISTRY, 1994, 33 (21) :6490-6494
[5]   POTENT INHIBITION OF INSULIN-RECEPTOR DEPHOSPHORYLATION BY A HEXAMER PEPTIDE-CONTAINING THE PHOSPHOTYROSYL MIMETIC F(2)PMP [J].
BURKE, TR ;
KOLE, HK ;
ROLLER, PP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (01) :129-134
[6]   PREPARATION OF FLUORO-4-(PHOSPHONOMETHYL)-D,L-PHENYLALANINE AND HYDROXY-4-(PHOSPHONOMETHYL)-D,L-PHENYLALANINE SUITABLY PROTECTED FOR SOLID-PHASE SYNTHESIS OF PEPTIDES CONTAINING HYDROLYTICALLY STABLE ANALOGS OF O-PHOSPHOTYROSINE [J].
BURKE, TR ;
SMYTH, MS ;
NOMIZU, M ;
OTAKA, A ;
ROLLER, PP .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (06) :1336-1340
[7]   VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates [J].
Chen, L ;
Montserat, J ;
Lawrence, DS ;
Zhang, ZY .
BIOCHEMISTRY, 1996, 35 (29) :9349-9354
[8]   Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics [J].
Combs, AP ;
Yue, EW ;
Bower, M ;
Ala, PJ ;
Wayland, B ;
Douty, B ;
Takvorian, A ;
Polam, P ;
Wasserman, Z ;
Zhu, WY ;
Crawley, ML ;
Pruitt, J ;
Sparks, R ;
Glass, B ;
Modi, D ;
McLaughlin, E ;
Bostrom, L ;
Li, M ;
Galya, L ;
Blom, K ;
Hillman, M ;
Gonneville, L ;
Reid, BG ;
Wei, M ;
Becker-Pasha, M ;
Klabe, R ;
Huber, R ;
Li, YL ;
Hollis, G ;
Burn, TC ;
Wynn, R ;
Liu, P ;
Metcalf, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6544-6548
[9]   High-throughput assays for promiscuous inhibitors [J].
Feng, BY ;
Shelat, A ;
Doman, TN ;
Guy, RK ;
Shoichet, BK .
NATURE CHEMICAL BIOLOGY, 2005, 1 (03) :146-148
[10]  
Grillo M.P., 2009, DRUG METAB HDB, P655